Skip to main content

Table 8 Analysis of over 50% percentage change of NLR in patients of response and non-response groups

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group

Trend

Decrease > 50%

Increase > 50%

No change

Total

Response

16

32

40

88

Non-response

2

10

19

31

Total

18

42

59

119

P value

0.187

  Â